Scott Biller
2017
In 2017, Scott Biller earned a total compensation of $2.3M as Chief Scientific Officer at Agios Pharmaceuticals, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $223,287 |
|---|---|
| Option Awards | $1,639,353 |
| Salary | $429,397 |
| Other | $9,840 |
| Total | $2,301,877 |
Biller received $1.6M in option awards, accounting for 71% of the total pay in 2017.
Biller also received $223.3K in non-equity incentive plan, $429.4K in salary and $9.8K in other compensation.
Rankings
In 2017, Scott Biller's compensation ranked 4,824th out of 14,666 executives tracked by ExecPay. In other words, Biller earned more than 67.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,824 out of 14,666 | 67th |
Division Manufacturing | 1,717 out of 5,772 | 70th |
Major group Chemicals And Allied Products | 510 out of 2,075 | 75th |
Industry group Drugs | 394 out of 1,731 | 77th |
Industry Pharmaceutical Preparations | 313 out of 1,333 | 77th |
Source: SEC filing on April 18, 2018.
Biller's colleagues
We found four more compensation records of executives who worked with Scott Biller at Agios Pharmaceuticals in 2017.